Technical Analysis for MCRB - Seres Therapeutics, Inc.

Grade Last Price % Change Price Change
C 20.66 -1.53% -0.32
MCRB closed down 1.53 percent on Thursday, May 13, 2021, on 1.13 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical MCRB trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish -1.53%
50 DMA Support Bullish -1.53%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.53%
Spinning Top Other -1.53%
Older End-of-Day Signals for MCRB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support about 16 hours ago
Outside Day about 16 hours ago
Fell Below Previous Day's Low about 16 hours ago
Down 2 % about 17 hours ago
Down 1% about 17 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Seres Therapeutics, Inc. Description

Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company's product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI to prevent the initial recurrence of CDI; SER-287 to treat inflammatory bowel disease, including ulcerative colitis; and SER-155 to treat enteric pathogens, such as antibiotic-resistant bacteria. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Development Autoimmune Diseases Antibiotic Inflammatory Bowel Disease Ulcer Colitis Ulcerative Colitis Diarrhea Antimicrobial Resistance Digestive Diseases Clostridioides Difficile Cdi Clostridium Difficile Clostridium Difficile Infection

Is MCRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 38.5
52 Week Low 3.67
Average Volume 946,801
200-Day Moving Average 24.38
50-Day Moving Average 20.55
20-Day Moving Average 20.89
10-Day Moving Average 21.05
Average True Range 1.84
ADX 22.97
+DI 27.47
-DI 11.40
Chandelier Exit (Long, 3 ATRs ) 17.95
Chandelier Exit (Short, 3 ATRs ) 24.19
Upper Bollinger Band 22.26
Lower Bollinger Band 19.51
Percent B (%b) 0.42
BandWidth 13.15
MACD Line 0.11
MACD Signal Line 0.11
MACD Histogram -0.0082
Fundamentals Value
Market Cap 1.89 Billion
Num Shares 91.2 Million
EPS -1.87
Price-to-Earnings (P/E) Ratio -11.07
Price-to-Sales 92.84
Price-to-Book 14.08
PEG Ratio -0.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.14
Resistance 3 (R3) 24.43 23.57 23.56
Resistance 2 (R2) 23.57 22.68 23.42 23.37
Resistance 1 (R1) 22.11 22.13 21.68 21.82 23.17
Pivot Point 21.25 21.25 21.03 21.10 21.25
Support 1 (S1) 19.79 20.36 19.36 19.50 18.15
Support 2 (S2) 18.93 19.81 18.78 17.95
Support 3 (S3) 17.47 18.93 17.76
Support 4 (S4) 17.18